Context sidebar

New on this website

12.01.2026

swissdamed Webinar: How to register and manage medical device data in swissdamed

On 28 May 2026, Swissmedic is hosting a free online training on how to register medical devices in swissdamed

12.01.2026

Change in Swissmedic top management: Executive Director Vincenza Trivigno takes up her post

On 12 January 2026, Vincenza Trivigno will take up her post as Executive Director of Swissmedic

08.01.2026

Batch recall – Locametz 25 mcg Mehrfachdosis-Kit für ein radioaktives Arzneimittel

Rückzug der Chargen PG21CH2507 und PG21CH2508 / Bulk Batch ID: F0392504 bis auf Stufe Detailhandel (Klinik / Spital)

08.01.2026

Out-of-Stock – Enrylaze 10 mg/Vial Injektionslösung

Befristete Bewilligung zum Vertrieb in irischer, schwedischer und finnischer Aufmachung

07.01.2026

Scientific GMDP Meetings for the clarification of GMP/GDP-related questions

A forum for the targeted clarification of project-specific GMP and GDP issues with Swissmedic

07.01.2026

Swissmedic Journal

Latest edition
Swissmedic Journal Dezember 2025

06.01.2026

Product Owner (80-100%)

Job advertisement | Division Operational Support Services

06.01.2026

Phosphonorm® administered instead of Phoscap capsules

Learning from adverse reaction reports – cases from pharmacovigilance

06.01.2026

Out-of-Stock – Xenpozyme Pulver zur Herstellung einer Lösung zur intravenösen Infusion

Befristete Bewilligung zum Vertrieb in taiwanesischer Aufmachung

06.01.2026

Updating of Annex 7 TPLRO – Revised list of variations

A revised list of variations according to Articles 21-24 TPO comes into force on 1 February 2026

01.01.2026

Fassung 12.1 der Europäischen Pharmakopöe in Kraft

Der Institutsrat hat die Fassung 12.1 der Europäischen Pharmakopöe auf den 1. Januar 2026 in Kraft gesetzt

01.01.2026

Changes to the Guidance documents Product information for veterinary medicinal products and Packaging texts for veterinary medicinal products

With effect from 1 January 2026, it will be possible to dispense with a paper copy of the package leaflet for certain veterinary medicinal products.

30.12.2025

Out-of-Stock – Sevelamercarbonate Salmon Pharma 800 mg Filmtabletten

Befristete Bewilligung zum Vertrieb in deutscher Aufmachung

29.12.2025

Summary report on authorisation – Pemazyre®

Extension of therapeutic indication (01)

23.12.2025

Batch recall – Esomeprazol MUT Sandoz magensaftresistente Tabletten

Rückzug der Chargen 239415, 239425, 239240, 239187, 239208, 239287, 239283 bis auf Stufe Detailhandel

23.12.2025

Batch recall – Ringerfundin B. Braun Infusionslösung

Rückzug der Charge 253527651 bis auf Stufe Detailhandel

23.12.2025

Summary report on authorisation – Jaypirca®

Extension of therapeutic indication (01)

23.12.2025

Summary report on authorisation – Sephience®

First authorisation

23.12.2025

Deadline for Device Registration in swissdamed

The registration of devices, systems, and procedure packs will become mandatory in swissdamed as of July 1, 2026, with a transition period until December 31, 2026

22.12.2025

Public consultation on ICH Guideline E22 “General Considerations for Patient Preference Studies” launched in Switzerland

Deadline of 12 April 2026 for comments

19.12.2025

Summary report on authorisation – Jeraygo®

First authorisation

18.12.2025

Leiter/in Human Resources (80-100%)

Job advertisement | Division Human Resources

18.12.2025

Out-of-Stock – Orfiril 300 mg/3 ml Injektionslösung

Befristete Bewilligung zum Vertrieb in deutscher Aufmachung

17.12.2025

Out-of-Stock – Hibidil sterile Lösung

Befristete Bewilligung zum Vertrieb in französischer Aufmachung

17.12.2025

Summary report on authorisation – Ryeqo®

Extension of therapeutic indication (01)

15.12.2025

Change to the review practice for medicinal products containing the active substance paclitaxel as paclitaxel albumin

Swissmedic is adapting its review practice for new applications for medicinal products containing the known active substance paclitaxel as paclitaxel albumin to the new EMA guideline

13.12.2025

Summary report on authorisation – Blenrep®

Extension of therapeutic indication (01)

12.12.2025

Two new members appointed to Swissmedic Agency Council

These appointments are part of the process of re-electing the entire Agency Council for the 2026–2029 period

12.12.2025

DHPC – Urapidil Stragen i.v. (urapidilum)

Beschädigtes Originalitätssiegel bei einigen Packungen

09.12.2025

Summary report on authorisation – Sarclisa®

Extension of therapeutic indication (02)

05.12.2025

Summary report on authorisation – Jemperli®

Extension of therapeutic indication (02)

05.12.2025

Summary report on authorisation – Tevimbra®

Extension of therapeutic indication (02)

05.12.2025

Summary report on authorisation – Tevimbra®

Extension of therapeutic indication (01)

05.12.2025

Aufsichtsabgabe 2025 – Selbstdeklaration

Eingabefrist: 23. Januar 2026

04.12.2025

DHPC – Rhophylac® (immunoglobulinum humanum anti-D)

Wichtige Mitteilung – Partikel

03.12.2025

Summary report on authorisation – Welireg®

Extension of therapeutic indication (01)

02.12.2025

Software-Architect (80-100%)

Job advertisement | Abteilung Informatik

02.12.2025

Cloud Engineer (80-100%)

Stellenausschreibung | Abteilung Informatik

01.12.2025

Meeting of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH)

The Assembly of the International Council for Harmonisation met in person on 18-19 November 2025 in Singapore

01.12.2025

Out-of-Stock – Nemluvio Pulver und Lösungsmittel zur Herstellung einer Injektionslösung im Fertigpen

Befristete Bewilligung zum Vertrieb in deutscher Aufmachung
Permanent link of this page
www.swissmedic.ch/updates-en
News channel of this page
Newsletter
New on the website

Last modification 01.12.2025

Top of page